发明名称 Compositions and Imaging Methods Comprising Detectably Labeled Phosphatidylethanolamine-Binding Peptides
摘要 Disclosed are surprising discoveries concerning the role of anionic phospholipids and aminophospholipids in tumor vasculature and in viral entry and spread, and compositions and methods for utilizing these findings in the treatment of cancer and viral infections. Also disclosed are advantageous antibody, immunoconjugate and duramycin-based compositions and combinations that bind and inhibit anionic phospholipids and aminophospholipids, for use in the safe and effective treatment of cancer, viral infections and related diseases.
申请公布号 US2014161724(A1) 申请公布日期 2014.06.12
申请号 US201314107240 申请日期 2013.12.16
申请人 Board of Regents, The University of Texas System 发明人 Thorpe Philip E.;He Jin
分类号 A61K51/08;A61K49/00;A61K49/14;C07K2/00 主分类号 A61K51/08
代理机构 代理人
主权项 1. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a substantially cell impermeant phosphatidylethanolamine (PE)-binding peptide that comprises a duramycin or cinnamycin peptide operatively attached to a cell impermeant group; wherein operative attachment of said duramycin or cinnamycin peptide to said cell impermeant group reduces the non-specific toxicity of the natural form of said duramycin or cinnamycin peptide by substantially inhibiting the ability of said duramycin or cinnamycin peptide to penetrate normal cells.
地址 Austin TX US